Theratechnologies, Inc. (TH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BioSyent, Inc.

HLS Therapeutics, Inc.

Medexus Pharmaceuticals, Inc.

InnoCan Pharma Corp.

Ayr Wellness, Inc.

Theratechnologies, Inc.

NervGen Pharma Corp.

Arch Biopartners, Inc.

Defence Therapeutics Inc

Cybin, Inc.

Mindset Pharma, Inc.

Why is Theratechnologies, Inc. ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 19.11% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 193.75%, its profits have risen by 42.2%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Theratechnologies, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Theratechnologies, Inc.

166.07%

0.23

85.94%

S&P/TSX 60

19.1%

1.54

14.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.03%

EBIT Growth (5y)

19.11%

EBIT to Interest (avg)

-2.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.18

Sales to Capital Employed (avg)

3.30

Tax Ratio

5.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

33.26%

ROCE (avg)

26.97%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-5.35

EV to EBIT

33.67

EV to EBITDA

24.67

EV to Capital Employed

36.32

EV to Sales

2.13

PEG Ratio

Dividend Yield

ROCE (Latest)

107.87%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CAD 9.72 MM

DEBT-EQUITY RATIO (HY)

Lowest at -120.69 %

DEBTORS TURNOVER RATIO(HY)

Highest at 6.89%

-17What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 6.32% (YoY

CASH AND EQV(HY)

Lowest at CAD 19.89 MM

NET SALES(Q)

Lowest at CAD 24.93 MM

OPERATING PROFIT(Q)

Lowest at CAD -2.15 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -8.61 %

PRE-TAX PROFIT(Q)

Lowest at CAD -4.55 MM

NET PROFIT(Q)

Lowest at CAD -4.76 MM

Here's what is working for Theratechnologies, Inc.

Operating Cash Flow

Highest at CAD 9.72 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Debt-Equity Ratio

Lowest at -120.69 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 6.89%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Theratechnologies, Inc.

Pre-Tax Profit

At CAD -4.55 MM has Fallen at -271.04%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -4.76 MM has Fallen at -294.43%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Net Sales

Lowest at CAD 24.93 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CAD MM)

Operating Profit

Lowest at CAD -2.15 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Operating Profit Margin

Lowest at -8.61 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CAD -4.55 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CAD MM)

Net Profit

Lowest at CAD -4.76 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)

Cash and Eqv

Lowest at CAD 19.89 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 6.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales